Literature DB >> 9843746

Overestimation of minimal model glucose effectiveness in presence of insulin response is due to undermodeling.

C Cobelli1, F Bettini, A Caumo, M J Quon.   

Abstract

Glucose effectiveness is an important determinant of glucose tolerance that can be derived from minimal model analysis of an intravenous glucose tolerance test (IVGTT). However, recent evidence suggests that glucose effectiveness is overestimated by minimal model analysis. Here we compare a new model-independent estimate of glucose effectiveness with the minimal model estimate by reanalyzing published data in which insulin-dependent diabetic subjects were each given IVGTTs under two conditions (Quon, M. J., C. Cochran, S. I. Taylor, and R. C. Eastman. Diabetes 43: 890-896, 1994). In one case, a basal insulin level was maintained (BI-IVGTT). In the second case, a dynamic insulin response was recreated (DI-IVGTT). Our results show that minimal model glucose effectiveness is very similar to the model-independent measurement during a BI-IVGTT but is three times higher during a DI-IVGTT. To investigate the causes of minimal model overestimation in the presence of a dynamic insulin response, Monte Carlo simulation studies on a two-compartment model of glucose kinetics with various insulin response patterns were performed. Results suggest that minimal model overestimation is due to single-compartment representation of glucose kinetics that results in a critical oversimplification in the presence of increasingly dynamic insulin secretion patterns.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9843746     DOI: 10.1152/ajpendo.1998.275.6.E1031

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  11 in total

1.  Ethnic differences in glucose disposal, hepatic insulin sensitivity, and endogenous glucose production among African American and European American women.

Authors:  Amy C Ellis; Jessica A Alvarez; Wesley M Granger; Fernando Ovalle; Barbara A Gower
Journal:  Metabolism       Date:  2011-11-08       Impact factor: 8.694

2.  A spectrum of dynamic insulin sensitivity test protocols.

Authors:  Paul D Docherty; J Geoffrey Chase; Lisa Te Morenga; Thomas F Lotz; Juliet E Berkeley; Geoffrey M Shaw; Kirsten A McAuley; Jim I Mann
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

Review 3.  The future of open- and closed-loop insulin delivery systems.

Authors:  Terry G Farmer; Thomas F Edgar; Nicholas A Peppas
Journal:  J Pharm Pharmacol       Date:  2008-01       Impact factor: 3.765

4.  Pharmacokinetic Modeling of the Glucoregulatory System.

Authors:  T G Farmer; T F Edgar; N A Peppas
Journal:  J Drug Deliv Sci Technol       Date:  2008-11       Impact factor: 3.981

5.  Diabetes: Models, Signals, and Control.

Authors:  Claudio Cobelli; Chiara Dalla Man; Giovanni Sparacino; Lalo Magni; Giuseppe De Nicolao; Boris P Kovatchev
Journal:  IEEE Rev Biomed Eng       Date:  2009-01-01

6.  Assessment of non-insulin-mediated glucose uptake: association with body fat and glycemic status.

Authors:  Reiner Jumpertz; Marie S Thearle; Joy C Bunt; Jonathan Krakoff
Journal:  Metabolism       Date:  2010-02-12       Impact factor: 8.694

7.  Effectiveness of Intravenous Infusion Algorithms for Glucose Control in Diabetic Patients Using Different Simulation Models.

Authors:  Terry G Farmer; Thomas F Edgar; Nicholas A Peppas
Journal:  Ind Eng Chem Res       Date:  2009-03-24       Impact factor: 3.720

Review 8.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

9.  Nonlinear modeling of the dynamic effects of infused insulin on glucose: comparison of compartmental with Volterra models.

Authors:  Georgios D Mitsis; Mihalis G Markakis; Vasilis Z Marmarelis
Journal:  IEEE Trans Biomed Eng       Date:  2009-06-02       Impact factor: 4.538

10.  Physiological modeling, tight glycemic control, and the ICU clinician: what are models and how can they affect practice?

Authors:  J Geoffrey Chase; Aaron J Le Compte; J-C Preiser; Geoffrey M Shaw; Sophie Penning; Thomas Desaive
Journal:  Ann Intensive Care       Date:  2011-05-05       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.